Education
About Us
Working with TipRanks
Follow Us
Charles Kummeth Insider Profile
4 Followers
Charles Kummeth, CEO, Director at Bio-Techne, holds 59.24K shares in Orthofix Medical (Ticker: OFIX), holds 21.64K shares in Gentherm (Ticker: THRM), holds 355.00K shares in Quantum-Si (Ticker: QSI).
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+11.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Kummeth holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Kummeth
Charles Kummeth's Trading History
Bio-Techne
Aug 17, 2023
CEO, Director
Uninformative Buy
757.85K
$75.47M
Gentherm
May 09, 2025
Director
Uninformative Buy
―
$709.31K
Orthofix Medical
Jun 23, 2025
Director
Uninformative Buy
―
$801.48K
Quantum-Si
Aug 13, 2024
Director
Informative Buy
148.21K
$339.38K
Sparton Corp
Mar 04, 2019
―
Uninformative Sell
299.64K
$0.00
List of latest transactions for each holding click on a transaction to see Charles Kummeth's performance on stock
You May Also Like
Charles Kummeth insider profile FAQ
What is the percentage of profitable transactions made by Charles Kummeth?
The percentage of profitable transactions made by Charles Kummeth is 80%.
What is the average return per transaction made by Charles Kummeth?
The average return per transaction made by Charles Kummeth is 11.50%.
What stocks does Charles Kummeth hold?
Charles Kummeth holds: TECH, THRM, OFIX, QSI, SPA stocks.
What was Charles Kummeth’s latest transaction?
Charles Kummeth latest transaction was an Uninformative Buy of ―.
What was Charles Kummeth's most profitable transaction?
Charles Kummeth’s most profitable transaction was an Informative Buy of QSI stock on August 13, 2024. The return on the trade was 28.50%.
What is Charles Kummeth's role in Bio-Techne?
Charles Kummeth's role in Bio-Techne is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.